This finding helped establish GLP-1 medications as legitimate cardiovascular protective agents, not just weight loss drugs
To correct for this, we performed RNA-seq analysis of hypothalami obtained from animals treated with daily injections of either GLP-1MK-801 or a dose of semaglutide that was equipotent in terms of weight-lowering efficacy over 5 days of treatment, that is, mice had achieved a comparable weight loss and reduction in food intake as that of GLP-1MK-801-treated mice (Extended Data Fig
This is where provider-led care truly shines
Monitor how your appetite feels, how your energy levels respond, whether fatigue patterns change, and how your relationship with food shifts
The turning point appears to happen around the two-month mark
The convenience of telehealth allows you to connect with expert providers from home, typically within 24 hours